VitroNordic ApS: Financial statements 2024
CVR: 43795260
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
VitroNordic ApS (CVR 43795260) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 765,789 and a net result of DKK 406,363 compared with DKK -3,403 the year before. That is an increase of 554.6% compared with the year before. Equity in the 2024 report amounted to DKK 622,960. The solvency ratio was 38.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 765,789
- Profit/Loss
- DKK 406,363
- Equity
- DKK 622,960
- Total Assets
- DKK 1,603,658
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 766 t. | 406 t. | 623 t. | 1 |
| 2023 | - | 117 t. | -3 t. | 217 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
VitroNordic ApS has published its annual report for 2023. Gross profit came to DKK 116,991, and the net result was DKK -3,403.
About VitroNordic ApS
VitroNordic ApS is a Danish company of the type Anpartsselskab based in Hasselager, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Lindhardsen. The company is owned by Future Life Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 923,732 and a net result of DKK 268,144 compared with DKK 406,363 the year before. Equity in the 2025 report amounted to DKK 891,104.